Clinical trial
Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of…
NCT00449553 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00449553 |
|---|---|
| Title | Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone. |
| Official title | A Prospective Study of Associations of Changes in HbA1C and Fasting Blood Lipids Due to Treatment With Pioglitazone for 6 Months and Genetic Polymorphism's in PPAR-gamma |
| Lead sponsor | Takeda, Industry |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Pioglitazone and sulphonylurea, Pioglitazone and metformin |
| Enrollment | 326 |
| Start date | Jun 1, 2001 |
| Primary completion | Sep 1, 2003 |
| Completion | Sep 1, 2003 |
| First posted | Mar 20, 2007 |
| Last update posted | Feb 28, 2012 |
| Countries | Denmark, Iceland, Norway, Sweden |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: